Over the past 12 months, 0 insiders at Cytek Biosciences, Inc. filed 0 open-market SEC Form 4 transactions on CTKB: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 2, 25 | William D. McCombeChief Financial Officer | BUY | 35.0K | $2.78 | $97K |
| Apr 19, 24 | Ming YanCHIEF TECHNOLOGY OFFICER | SELL | 20.0K | $5.87 | $117K |
| Apr 9, 24 | Ming YanCHIEF TECHNOLOGY OFFICER | SELL | 1.5K | $7.01 | $11K |
| Mar 19, 24 | Ming YanCHIEF TECHNOLOGY OFFICER | SELL | 20.0K | $6.71 | $134K |
| Mar 18, 24 | Ming YanCHIEF TECHNOLOGY OFFICER | SELL | 20.0K | $6.77 | $135K |
| Dec 26, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $9.50 | $29K |
| Dec 19, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $9.43 | $189K |
| Nov 24, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $6.94 | $21K |
| Nov 20, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $6.03 | $121K |
| Nov 7, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $4.34 | $87K |
| Oct 24, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $4.68 | $14K |
| Oct 19, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $4.80 | $96K |
| Oct 9, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $5.33 | $107K |
| Sep 25, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $6.38 | $19K |
| Sep 19, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $6.49 | $130K |
| Sep 7, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $6.83 | $137K |
| Aug 24, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $7.69 | $23K |
| Aug 21, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $8.07 | $161K |
| Aug 7, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $9.04 | $181K |
| Jul 24, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $9.17 | $28K |
| Jul 19, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $8.76 | $175K |
| Jul 7, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $8.48 | $170K |
| Jun 26, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $7.96 | $24K |
| Jun 20, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $8.18 | $164K |
| Jun 7, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $8.23 | $165K |
| May 24, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $7.76 | $23K |
| May 19, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $7.19 | $144K |
| May 8, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $11.55 | $231K |
| Apr 24, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $10.24 | $31K |
| Apr 19, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $9.71 | $194K |
| Apr 10, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $8.88 | $178K |
| Mar 24, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $8.33 | $25K |
| Mar 20, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $9.29 | $186K |
| Mar 7, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $10.13 | $203K |
| Feb 24, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.0K | $11.05 | $33K |
| Feb 21, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $10.94 | $219K |
| Feb 8, 23 | Ming YanChief Technology Officer | SELL | 897 | $13.53 | $12K |
| Feb 7, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $13.19 | $264K |
| Feb 3, 23 | Ming YanChief Technology Officer | SELL | 1.1K | $13.51 | $15K |
| Jan 24, 23 | Patrik JeanmonodChief Financial Officer | SELL | 3.5K | $11.05 | $39K |
| Jan 19, 23 | Ming YanChief Technology Officer | SELL | 20.0K | $11.03 | $221K |
| Jan 9, 23 | Wenbin JiangPresident and CEO | SELL | 20.0K | $10.66 | $213K |
| Dec 27, 22 | Patrik JeanmonodChief Financial Officer | SELL | 3.5K | $9.77 | $34K |
| Dec 19, 22 | Ming YanChief Technology Officer | SELL | 20.0K | $10.38 | $208K |
| Dec 7, 22 | Wenbin JiangPresident and CEO | SELL | 20.0K | $11.86 | $237K |
| Nov 25, 22 | Patrik JeanmonodChief Financial Officer | SELL | 3.5K | $14.30 | $50K |
| Nov 21, 22 | Ming YanChief Technology Officer | SELL | 20.0K | $14.66 | $293K |
| Nov 14, 22 | Jack BallDirector | SELL | 16.0K | $14.69 | $235K |
| Nov 7, 22 | Wenbin JiangPresident and CEO | SELL | 20.0K | $14.76 | $295K |
| Oct 24, 22 | Patrik JeanmonodChief Financial Officer | SELL | 3.5K | $15.16 | $53K |
Over the past 12 months, insiders at Cytek Biosciences, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on CTKB, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market CTKB insider purchase in our data was $97K by William D. McCombe, Chief Financial Officer, filed on Jun 2, 25.
0 different insiders at Cytek Biosciences, Inc. filed open-market SEC Form 4 transactions on CTKB over the last 12 months.
InsiderTape plots every CTKB insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Cytek Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →